Latest Issue

The “genomic revolution” is coming—and it will transform the NHS

The ability to analyse people’s genetic constitutions will transform cancer care over the coming years. But to make the most of the technology, highly sensitive data will need to be shared. That presents problems

By Philip Ball  

“It’s here already, and I believe it’s going to transform the NHS in the next 5-10 years.” Sally Davies, Chief Medical Officer (CMO) for England in the civil service, is talking about the “genomic revolution.” The annual report that she has just released—a regular component of the CMO’s advice to government—is focused on what genomic technologies can do for public health; it is called “Generation Genome.” She spoke about these prospects on 4th July at an event at the Wellcome Collection in London organised by the charity Progress Educational Trust (PET),…

Register today to continue reading

You’ve hit your limit of three articles in the last 30 days. To get seven more, simply enter your email address below.

You’ll also receive our free e-book Prospect’s Top Thinkers 2020 and our newsletter with the best new writing on politics, economics, literature and the arts.

Prospect may process your personal information for our legitimate business purposes, to provide you with newsletters, subscription offers and other relevant information.

Click here to learn more about these purposes and how we use your data. You will be able to opt-out of further contact on the next page and in all our communications.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We want to hear what you think about this article. Submit a letter to

More From Prospect